Johnson Fistel is currently investigating a number of publicly traded companies for allegedly violating state and federal laws, some of which are already named as a defendant in a securities fraud class action.

Pending Class Actions

For more information about existing securities fraud class actions, including upcoming important deadlines, please click here.

Investigations

For more information about ongoing investigations, please click on the name of the company below.

TXNM Energy, Inc.

Johnson Fistel Investigates Fairness of Proposed Sale of TXNM Energy, Inc.   Johnson Fistel, PLLP has launched an investigation into whether the board members of TXNM Energy, Inc. (NYSE: TXNM) breached their fiduciary duties in connection with the proposed sale of the Company to Blackstone Infrastructure. On May 19, 2025, TXNM Energy  announced it had entered into a definitive agreement with Blackstone to acquire all outstanding shares in a go-private transaction, offering shareholders $61.25 per share in cash. If you are a shareholder of TXNM Energy  and believe the proposed buyout price is too low or if you’re interested in learning more about the investigation, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number. About Johnson Fistel, PLLP | Top Law Firm for Securities Fraud and Investors Rights:Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. We also extend our services to foreign investors who have purchased on US exchanges. Stay informed about stock-related developments and learn how Johnson Fistel, PLLP may help you recover investment losses.

Read More »

Regeneron Pharmaceuticals, Inc.

Johnson Fistel, PLLP is investigating claims on behalf of Regeneron Pharmaceuticals, Inc. against certain of its officers and directors. If you are a current, long-term shareholder of Regeneron, continuously holding shares since November 2, 2023, you may have standing to hold the company harmless from the alleged harm caused by the Company’s officers and directors by making them personally responsible. You may also be able to assist in reforming the Company’s corporate governance to prevent future wrongdoing. You can click or copy and paste the link below in a browser to join this action: Previously, a class action complaint was filed against the company. The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, the Complaint alleges Defendants failed to disclose to investors: (1) that Regeneron paid credit card fees to distributors on the condition that distributors did not charge Eylea customers more to use a credit card; (2) that these payments subsidized the prices that customers paid when using credit cards to purchase Eylea; (3) that, as a result, Regeneron offered a price concession that lowered Eylea’s

Read More »

Autodesk, Inc.

Johnson Fistel, PLLP investigates Autodesk on Behalf of Shareholders San Diego, May 13, 2025 – Johnson Fistel, PLLP is investigating whether Autodesk, Inc. (NASDAQ: ADSK) its executive officers or others, or other associated parties may have violated one or more federal and/or state laws. What if I purchased Autodesk securities? If you purchased securities join our investigation now: For more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471 There is no cost or obligation to you. What is Johnson Fistel investigating? The investigation will ascertain whether Autodesk’s corporate governance practices adhere to established legal precedents concerning the fiduciary duties owed by its officers or other associated parties. About Johnson Fistel, PLLP | Top Law Firm, Securities Fraud, Investors Rights:Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. We also extend our services to foreign investors who have purchased on US exchanges. Stay updated with news on stock drops and learn how Johnson Fistel, PLLP can help you recover your losses. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Achievements: In 2024, Johnson

Read More »

Landsea Homes Corporation

Johnson Fistel Investigates Fairness of Proposed Sale of Landsea to New Home Co. and its Majority Shareholder Apollo. San Diego – GlobeNewswire—May 13, 2025 Johnson Fistel, PLLP has launched an investigation into whether the board members of Landsea Homes Corporation (NASDAQ: LSEA) breached their fiduciary duties in connection with the proposed sale of the Company to New Home, a portfolio company of funds managed by affiliates of Apollo Global Management (NYSE: APO) On May 12, 2025, Landsea announced it had entered into a definitive agreement for New Home Co. to acquire all outstanding shares in a go-private transaction, offering shareholders $11.30 per share in cash — a price below both the prior 12-month high of $14.04 and a Wall Street analyst’s $18.00 price target. If you are a shareholder of Landsea and believe the proposed buyout price is too low or if you’re interested in learning more about the investigation, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number. About Johnson Fistel, PLLP | Top Law Firm for Securities Fraud and Investors Rights:Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The

Read More »

TaskUs, Inc.

Johnson Fistel Investigates Fairness of Proposed Sale of TaskUs, Inc. Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of TaskUs, Inc. (NASDAQ: TASK) breached their fiduciary duties in connection with the proposed sale of the Company to Blackstone, TaskUs Co-Founder and Chief Executive Officer Bryce Maddock and TaskUs Co-Founder and President Jaspar Weir (collectively the “Buyer Group”) On May 9, 2025, TaskUs entered into a definitive agreement pursuant to which Buyer Group will acquire all outstanding shares of the Company. Under the terms of the agreement, each holder of TaskUs common stock will receive only $16.50 in cash per share. Over the twelve-month period preceding the announcement Task stock traded as high as $19.60 and over $70 several years earlier. If you are a shareholder of TaskUs and believe the proposed buyout price is too low or you’re interested in learning more about the investigation, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number. About Johnson Fistel, PLLP:  Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Colorado, and Idaho. The firm represents individual and institutional investors

Read More »

TransMedics Group, Inc.

Johnson Fistel, PLLP is investigating claims on behalf TransMedics Group, Inc. against certain of its officers and directors. If you are a current, long-term shareholder of TransMedics Group continuously holding shares since February 28, 2023, you may have standing to hold the company harmless from the alleged harm caused by the Company’s officers and directors by making them personally responsible. You may also be able to assist in reforming the Company’s corporate governance to prevent future wrongdoing. You can click or copy and paste the link below in a browser to join this action: Previously, a class action complaint was filed against the company. The complaint alleges that TransMedics made false and misleading statements, while failing to disclose crucial information. Specifically, the suit contends that TransMedics used kickbacks, fraudulent overbilling, and coercive tactics to boost business and revenue. Furthermore, it alleges that the company engaged in unsafe practices, concealed safety problems, and generally lacked adequate safety oversight, exposing TransMedics to heightened regulatory risk. 

Read More »

Skechers U.S.A., Inc.

Johnson Fistel Investigates Proposed Sale of Skechers and Whether Shareholders Being Treated Fairly Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of Skechers U.S.A., Inc. (NYSE: SKX) breached their fiduciary duties in connection with the proposed sale of the Company to 3G Capital Corp. (“3G”). On May 5, 2025, Skechers entered into a definitive agreement pursuant to which 3G will acquire all outstanding shares of the Company in a go-private transaction. Under the terms of the agreement, each holder of Company common stock may elect to receive either $63.00 in cash per share or $57.00 in cash per share plus one unit in the post-closing private entity controlled by 3G. The post-closing units will be subject to customary and numerous other restrictions on transfer. Over the twelve-month period preceding the announcement, Skechers common stock traded at levels approaching $80.00 per share. If you are a shareholder of Sketchers and believe the proposed buyout price is too low or you’re interested in learning more about the investigation, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number. About Johnson Fistel, PLLP | Top Law Firm, Securities Fraud, Investors

Read More »

Methode Electronics, Inc.

Investor Alert: Methode Electronics, Inc: Johnson Fistel, PLLP Investigates Claims on Behalf of Investors Johnson Fistel, PLLP is investigating claims on behalf of Methode Electronics, Inc. against certain of its officers and directors. If you are a current, long-term shareholder of the company, continuously holding your shares since June 23, 2022, you may have standing to hold the company harmless from the alleged harm caused by the Company’s officers and directors by making them personally responsible. You may also be able to assist in reforming the Company’s corporate governance to prevent future wrongdoing. Previously a class action complaint was filed against the company. The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Methode had lost highly skilled and experienced employees during the COVID-19 pandemic necessary to successfully complete Methode’s transition from its historic low mix, high volume production model to a high mix, low production model at its Monterrey facility; (2) Methode’s attempts to replace its General Motors center console production with more diversified, specialized products for a wider array of vehicle manufacturers and OEMs, in particular in the electric vehicle (“EV”) space, had been plagued by production

Read More »

Ibotta, Inc.

Ibotta, Inc. Shareholders Who Lost Money on Their Investment are Encouraged to Contact Johnson Fistel about the Class Action Lawsuit Johnson Fistel, PLLP announces that a class action lawsuit has commenced on behalf of investors of Ibotta, Inc. (NYSE: IBTA). The lawsuit seeks to recover losses on behalf of investors who acquired their securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Ibotta’s April 18, 2024 initial public offering (the “IPO”). If you wish to serve as lead plaintiff, you must move the Court no later than June 16, 2025. If you incurred significant losses and want to act as the lead plaintiff in the class action lawsuit or determine if you are eligible to receive a potential recovery of your losses, follow the link provided: For more information, contact James Baker, (619) 814-4471, jimb@johnsonfistel.com or fjohnson@johnsonfistel.com The Complaint alleges that statements made in the Registration Statement issued in connection with Ibotta’s April 18, 2024 initial public offering were false and/or misleading when made because they did not properly warn investors of the risks concerning Ibotta’s contract with The Kroger Co. Kroger’s contract was at-will, and Ibotta failed to warn investors

Read More »

TechTarget, Inc.

Johnson Fistel, PLLP Investigates TechTarget on Behalf of Shareholders Who Incurred Losses Johnson Fistel, PLLP is investigating whether TechTarget, Inc.  (NASDAQ: TTGT) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose information to investors. What if I purchased TechTarget securities? If you purchased securities and suffered losses on your investment, join our investigation now: For more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471 There is no cost or obligation to you. What is Johnson Fistel investigating? On December 6, 2024, TechTarget announced that its previously issued financial statements, including those incorporated in the Company’s Registration Statement and pertaining to the Informa Tech Digital Businesses of Informa PLC, should no longer be relied upon and were being restated due to the identification of certain errors. Following this news, the price of TechTarget’s stock experienced a significant decline, adversely impacting investors. Subsequently, on March 31, 2025, TechTarget further revealed that it was unable to timely file its 2024 Annual Report as it continued to evaluate technical accounting matters associated with its combination with the Informa Tech Digital Businesses. Following this second disclosure, TechTarget’s stock price declined further. About Johnson Fistel, PLLP | Top Law Firm,

Read More »

Otter Tail Corporation

Johnson Fistel, PLLP is investigating claims on behalf of Otter Tail Corporation (NASDAQ: OTTR) against certain of its officers and directors. If you are a current, long-term shareholder of Otter Tail and continuously hold shares, you may have standing to hold the company harmless from the alleged harm caused by the Company’s officers and directors by making them personally responsible. You may also be able to assist in reforming the Company’s corporate governance to prevent future wrongdoing.  On August 23, 2024, a class action lawsuit was filed in the U.S. District Court for the Northern District of Illinois. This lawsuit represents a putative class of all purchasers of PVC municipal water or electrical conduit pipe through distributors and alleges that Otter Tail, along with other PVC pipe manufacturers, has violated U.S. antitrust laws.In addition, subsequent lawsuits echoing similar claims were filed on September 3, September 11, and September 26, 2024. Furthermore, on August 27, 2024, Otter Tail received a grand jury subpoena from the U.S. Department of Justice, Antitrust Division, issued by the U.S. District Court for the Northern District of California. This subpoena requests the production of documents related to the manufacturing, selling, and pricing of PVC pipe.

Read More »

DexCom, Inc.

Johnson Fistel has Commenced an Investigation on Behalf of DexCom, Inc. Shareholders Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of DexCom, Inc. (NASDAQ: DXCM) for potential breaches of fiduciary duties and violations of the federal securities laws. What is Johnson Fistel Investigating? Between April 28, 2023 and June 5, 2024, certain DexCom insiders caused the company to issue false and misleading public statements regarding its expansion strategy and purported market share. However, beginning on April 25, 2024, DexCom made its first in a series of public corrective disclosures announcing that the company’s growth and business prospects were far lower than it had previously claimed. By the time the company made its final corrective disclosure on July 25, 2024, the price of DexCom’s shares had plummeted by over 40.6%. Current stockholders who held their DexCom stock before April 28, 2023, are encouraged to contact Johnson Fistel to discuss their legal rights in this matter. You can click or copy and paste the following link to join this investigation: About Johnson Fistel, PLLP:Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York,

Read More »